Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-12-05 15:49:26 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Third Quarter 2014 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its third quarter 2014 investor
conference webinar scheduled on December 9, 2014 at 16:00
(EET). Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities
and analyse the financial results of the third quarter 2014.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till December 8 to e-mail: ieva.kadakovska@nasdaq.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar For more
information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia Information
prepared by: |
Pielikumi |
|